[1] SIDIANE B, SIDNEY G, SILVIA M, et al.A Concise and Useful Guide to Understand How Alpha1 Adrenoceptor Antagonists Work[J]. Mini Rev Med Chem, 2022, 22(18): 2383-2405. [2] ZENG AB, ZHANG R.Clinical Study on the Treatment of Benign Prostatic Hyperplasia with the Combination of Terazosin and Transu-rethral Resection of the Prostate (TURP)[J]. China Pharmaceuticals(中国药业), 2020, 29(20): 75-78. [3] LI M, TAO YH, CHOU NJ, et al.Research Progress in the Pharmacology of Terazosin[J]. Central South Pharmacy(中南药学), 2024, 22(4): 1016-1022. [4] SCHWEIGER V, NIEDERSEER D, SCHMIED C, et al.Athletes and Hypertension[J]. Curr Cardiol Rep, 2021, 23(12): 176. [5] ZHANG PW, FAN LL, GAN CY, et al.Safety Analysis of Terazosin in Chinese Healthy Subjects[J]. Practical Journal of Clinical Medicine(实用医院临床杂志), 2023, 20(4): 82-85. [6] LIU YN, HU YY, ZHANG HY, et al.The Therapeutic Effect of Terazosin Hydrochloride Tablets Combined with Losartan Potassium on Hypertensive Patients and Its Impact on Oxidative Stress Response[J]. China Medicine(中国医药), 2020, 15(6): 859-863. [7] STROM JA, ZOLA B, FRISHMAN W, et al.Acute Hemodynamic Effects of Terazosin in Hypertensive and Normotensive Patients[J]. American Heart Journal, 1991, 122(32): 892-900. [8] CAMPANERO MA, SADABA B, MUNOZ-JUAREZ MJ, et al.Pharmacokinetic Andpharmacodynamic Modelling of Arterial Haemodynamic Effects of Terazosinin Healthy Volunteers[J]. Clin Drug Investig, 2008, 28(3): 139-147. [9] YANG JM, YANG W, LIU JY.Study on the Therapeutic Effect and Safety of Spironolactone, Terazosin, and Bisoprolol in Patients with Refractory Hypertension[J]. Chinese General Practice(中国全科医学), 2018, 21(31): 3845-3849. [10] PENG DB, PENG Y.Analysis of 92 Adverse Reaction/Event Reports of Terazosin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2011, 8(8): 504-505. [11] XU L, FENG JW, LANG JT, et al.Clinical Comparison of Three Different Alpha Receptor Blockers in the Treatment of Patients with Benign Small Volume Prostatic Hyperplasia Accompanied by Lower Urinary Tract Symptoms[J]. Journal of North Sichuan Medical College(川北医学院学报), 2023, 38(6): 810-813, 817. [12] QI LY.Pharmacists Use the Norris Assessment Scale to Consult on Adverse Drug Reactions and Their Thoughts[J]. Journal of Traditional Chinese Medicine Management(中医药管理杂志), 2022, 30(24): 86-88. [13] LI H, CAI W.The Pathogenesis and Treatment Progress of Atrial Fibrillation[J]. Journal of Practical Electrocardiology JS(实用心电学杂志), 2024, 33(1): 87-92. [14] QIN M, ZENG C, LIU X.The Cardiac Autonomic Nervous System: a Target for Modulation of Atrial Fibrillation[J]. Clin Cardiol, 2019, 42(6): 644-652. [15] XI Y, CHENG J.Dysfunction of the Autonomic Nervous System in Atrial Fibrillation[J]. J Thorac Dis, 2015, 7(2): 193-198. |